Comparison of Sonication Patterns and Microbubble Administration Strategies for Focused Ultrasound-Mediated Large-Volume Drug Delivery.
Authors: Gong Y, Ye D, Chien CY, Yue Y, Chen H
Diffuse intrinsic pontine glioma (DIPG) is the most common and deadliest brainstem tumor in children. Focused ultrasound combined with microbubble-mediated BBB opening (FUS-BBBO) is a promising technique for overcoming the frequently intact blood-brain barrier (BBB) in DIPG to enhance therapeutic drug delivery to the brainstem. Since DIPG is highly diffusive, large-volume FUS-BBBO is needed to cover the entire tumor region. The objective of this study was to determine the optimal treatment strategy to achieve efficient and homogeneous large-volume BBBO at the brainstem for the delivery of an immune checkpoint inhibitor, anti-PD-L1 antibody (aPD-L1). Two critical parameters for large-volume FUS-BBBO, multi-point sonication pattern (interleaved vs. serial) and microbubble injection method (bolus vs. infusion), were evaluated by treating mice with four combinations of these two parameters. 2D Passive cavitation imaging (PCI) was performed for monitoring the large-volume sonication. Interleaved sonication combined with bolus injection of microbubbles resulted in 1.29 to 2.06 folds higher efficiency than other strategies as evaluated by Evans blue extravasation. The average coefficient of variation of the Evans blue delivery was 0.66 for interleaved sonication with bolus injection, compared to 0.68-0.88 for all other strategies. Similar trend was also observed in the quantified total cavitation dose and coefficient of variance of the cavitation dose. This strategy was then applied to deliver fluorescently labeled aPD-L1 which was quantified using fluorescence imaging. A strong segmented linear correlation (R<sup>2</sup> = 0.81) was found between the total cavitation dose and the total fluorescence intensity of aPD-L1 delivered at different sonication pressures (0.15 MPa, 0.30 MPa, and 0.45 MPa). Findings from this study suggest that efficient and homogeneous large-volume FUS-BBBO can be achieved by interleaved sonication combined with bolus injection of microbubbles, and the efficiency and homogeneity can be monitored by PCI.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
Determine the optimal multi-point sonication pattern and microbubble injection method to achieve efficient, homogeneous large-volume blood–brain barrier opening in the brainstem for delivery of anti-PD-L1.
Animal model / Human subject
Mouse (strain not specified; age not specified; sex not specified)
Disease model
Diffuse intrinsic pontine glioma (DIPG)
MRI or image guidance method
2D Passive cavitation imaging (PCI)
Targeted brain region(s)
Brainstem
Cargo name and characteristics
Anti-PD-L1 antibody (aPD-L1) — protein therapeutic (immune checkpoint inhibitor), fluorescently labeled for delivery quantification; Evans blue — small-molecule dye used to assess blood–brain barrier opening/extravasation
Outcomes and Safety
Summary of Outcomes
Interleaved multi-point sonication combined with bolus microbubble injection produced more efficient and homogeneous large-volume BBB opening at the brainstem (1.29–2.06× higher Evans blue extravasation; CV=0.66 vs 0.68–0.88 for other strategies) compared with serial sonication or infusion. Total cavitation dose correlated strongly with delivery of fluorescent aPD-L1 across sonication pressures (0.15, 0.30, 0.45 MPa; R²=0.81); tested parameters were sonication pattern (interleaved vs serial) and microbubble injection method (bolus vs infusion), with interleaved+bolus successful.
Safety-related matter
The provided text contains no mention of safety assessments, adverse effects, or toxicity; no adverse events were reported.
Brain Region
Ultrasound Parameters
FUS Pressure
0.15 MPa, 0.30 MPa, 0.45 MPa
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency
Single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search